Nemaura Medical Inc. (NMRD) financial statements (2021 and earlier)

Company profile

Business Address 57 WEST 57TH STREET
MANHATTAN, NY 10019
State of Incorp.
Fiscal Year End March 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,0683,7418229119,404355
Cash and cash equivalents1,0683,7418229119,404355
Inventory, net of allowances, customer advances and progress billings23038    
Inventory23038    
Prepaid expense     248
Other undisclosed current assets4447365,1761,919148164
Total current assets:1,7414,5155,9992,8309,552766
Noncurrent Assets
Property, plant and equipment    814
Intangible assets, net (including goodwill)    173133
Intangible assets, net (excluding goodwill)    173133
Other noncurrent assets422249257213  
Other undisclosed noncurrent assets   4,359  
Total noncurrent assets:4222492574,572181147
TOTAL ASSETS:2,1644,7646,2557,4029,733913
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18416150787366
Accounts payable18416150787366
Deferred revenue66
Due to related parties7029656146889155
Other liabilities191108148874941
Other undisclosed current liabilities 65    
Total current liabilities:1,1431,299811852658122
Noncurrent Liabilities
Liabilities, other than long-term debt  1,3331,1831,3961,708
Deferred revenue and credits1,3331,1831,3961,538
Accounts payable and accrued liabilities     170
Other undisclosed noncurrent liabilities1,2551,238    
Total noncurrent liabilities:1,2551,2381,3331,1831,3961,708
Total liabilities:2,3982,5372,1442,0352,0541,831
Stockholders' equity
Stockholders' equity attributable to parent, including:(235)2,2274,1115,367769(917)
Preferred stock  0   
Common stock2120868205205200
Additional paid in capital16,37315,78513,05712,92012,9202,925
Accumulated other comprehensive income (loss)(389)(340)(41)(606)15520
Accumulated deficit(16,239)(13,426)(8,973)(7,153)(5,601)(4,062)
Other undisclosed stockholders' equity attributable to parent    (6,910) 
Other undisclosed stockholders' equity    6,910 
Total stockholders' equity:(235)2,2274,1115,3677,679(917)
TOTAL LIABILITIES AND EQUITY:2,1644,7646,2557,4029,733913

Income statement (P&L) ($ in thousands)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Net investment income42489   
Gross profit:42489   
Operating expenses(5,056)(4,477)(1,909)(1,551)(1,540)(1,320)
Other undisclosed operating loss(4)(24)(89)   
Operating loss:(5,056)(4,477)(1,909)(1,551)(1,540)(1,320)
Nonoperating income (expense)
(Foreign Currency Transaction Gain (Loss), before Tax)
(36)2699(994)47(79)
Loss from continuing operations before equity method investments, income taxes:(5,092)(4,451)(1,810)(2,545)(1,493)(1,399)
Other undisclosed income (loss) from continuing operations before income taxes(2)(2)(10)994(47)79
Loss from continuing operations before income taxes:(5,093)(4,453)(1,820)(1,551)(1,540)(1,320)
Income tax benefit614     
Loss before gain (loss) on sale of properties:(4,479)(4,453)(1,820)(1,551)(1,540)(1,320)
Other undisclosed net income65     
Net loss:(4,414)(4,453)(1,820)(1,551)(1,540)(1,320)
Other undisclosed net loss attributable to parent(24)     
Net loss available to common stockholders, diluted:(4,438)(4,453)(1,820)(1,551)(1,540)(1,320)

Comprehensive Income ($ in thousands)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Net loss:(4,414)(4,453)(1,820)(1,551)(1,540)(1,320)
Other comprehensive income (loss) (299)565(761)13629
Other undisclosed comprehensive loss(299)     
Comprehensive loss:(4,713)(4,752)(1,256)(2,312)(1,404)(1,291)
Other undisclosed comprehensive income, net of tax, attributable to parent239     
Comprehensive loss, net of tax, attributable to parent:(4,474)(4,752)(1,256)(2,312)(1,404)(1,291)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: